Silence Therapeutics plc SLNCF

SLNCF

Silence Therapeutics plc

Exchange: nyse

Multiples

P/E:
P/BV: 4.42
P/TBV: 29.22

Description:

none

Data:

Market Cap

269123584.00

EBITDA

Net Income

Yields:

Earnings Yield

Return on Capital

CAGR (net income)

0%

CAGR Length

0

Dividend Rate